Twitter

Archive for June 2nd, 2011


Leukemia drug tied to impaired growth in kids

… (Reuters Health) – Children taking the drug Gleevec for a rare form of childhood leukemia may show a slow-down in their growth — at least if they start the …

Read More...

Medco Partners With MolecularMD on Personalized Medicine Program for Chronic Myeloid Leukemia

… MolecularMD Corp. today announce the launch of a personalized medicine program for chronic myeloid leukemia (CML) patients. Through this program, Medco will offer patients diagnosed with CML a molecular …

Read More...

Lenalidomide, Lenalidomide + Azacitidine, or Standard Treatment Therapies in Newly Diagnosed Acute Myeloid Leukemia

Conditions :   Acute Myeloid Leukemia;   Acute Myelogenous Leukemia Interventions :   Drug: Azacitidine;   Drug: Lenalidomide - single agent;   Drug: Cytarabine - intravenous;   Drug: Cytarabine - subcutaneous;   Drug: Lenalidomide in combination;   Drug: Daunorubicin;   Drug: Idarubicin Sponsor :   Celgene Corporation Not yet recruiting – verified May 2011

Read More...

Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism

Condition :   Polycystic Ovary Syndrome Intervention :   Drug: folate-boosted 3 mg DRSP/20 ?g EE-24/4 oral contraceptive Sponsors :   BC Women’s Hospital & Health Centre;   Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma Not yet recruiting – verified May 2011

Read More...

Darbepoetin Alfa in Anemic Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) Subjects

Condition :   MDS Interventions :   Drug: Darbepoetin alfa;   Drug: Placebo Sponsor :   Amgen Not yet recruiting – verified May 2011

Read More...

Palliation: the Effect of Education on Pain

Condition :   Bone Metastases Interventions :   Behavioral: Pain education;   Behavioral: No Pain education Sponsors :   University Medical Centre Groningen;   ZonMw: The Netherlands Organisation for Health Research and Development;   Kankerbestrijding Recruiting – verified May 2011

Read More...

Hepatitis A Vaccine in Patients With Immunomodulating Drugs

Condition :   Response to Hepatitis A Vaccine Intervention :   Biological: hepatitis A vaccine ( HAVRIX or EPAXAL) Sponsor :   Sormland County Council, Sweden Completed – verified May 2011

Read More...

Clinical Evaluation of Novel Biomarkers in Patients With Septicemia

Conditions :   Sepsis;   Bacteremia;   Fungemia Intervention :   Sponsor :   Medical University of Graz Recruiting – verified May 2011

Read More...

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

Condition :   Juvenile Idiopathic Arthritis Intervention :   Sponsor :   Bristol-Myers Squibb Not yet recruiting – verified May 2011

Read More...

Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma

Condition :   Malignant Melanoma, Metastatic Interventions :   Biological: Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF);   Biological: Ipilimumab Sponsors :   Northern California Melanoma Center;   University of California, San Francisco Recruiting – verified May 2011

Read More...